This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Odyssey HealthCare, Inc.

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Odyssey HealthCare, Inc. (“Odyssey” or the “Company”) (NASDAQ:ODSY) related to the Company’s agreement to be acquired by Gentiva Health Services, Inc. (“Gentiva”). The proposed all-cash transaction is valued at approximately $1 billion.

Under the terms of the definitive merger agreement entered into by the parties, Gentiva will acquire Odyssey for $27.00 in cash for each share of the Company’s common stock. The transaction is expected to be completed in the third quarter of 2010. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Odyssey’s board of directors.

If you own shares of Odyssey, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to, or visit our website at

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $111.47 1.80%
FB $93.19 0.78%
GOOG $642.95 0.59%
TSLA $221.77 -2.20%
YHOO $32.39 0.06%


Chart of I:DJI
DOW 17,061.81 +11.06 0.06%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,828.4630 +17.6750 0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs